Search results
For severe infections in infants and children, the success of antimicrobial treatment depends primarily on rapid clinical diagnosis of the disease, identification of the responsible pathogen or pathogens, and, when indicated, effective surgical drainage and debridement.
6 lut 2024 · This organism is important because it is often antibiotic resistant and can cause severe hospital-acquired infections associated with a high mortality rate, especially in immunocompromised hosts. The principles of antimicrobial treatment of infections caused by P. aeruginosa will be reviewed here.
Ceftolozane-tazobactam, a beta-lactam/beta-lactamase inhibitor, is a relatively novel antibiotic showing efficacy in treating Pseudomonas infections (urinary tract, intra-abdominal, and pulmonary infections at double doses) (Aspect trials) [115,116,117].
29 maj 2018 · Clinical approaches to patients with bacteremia, ventilator-associated pneumonia, urinary tract infections and skin soft tissue infections are discussed. Antibiotic combinations are reviewed as well as an analysis of pharmacokinetic and pharmacodynamic parameters to optimize P. aeruginosa treatment.
21 lip 2023 · How is a Pseudomonas aeruginosa infection treated? A healthcare provider will usually recommend antibiotics to treat a Pseudomonas aeruginosa infection. They may prescribe one or more of the following: Aztreonam. Carbapenems. Ceftazidime. Ciprofloxacin. Gentamicin. Ticarcillin. Ureidopenicillins.
18 lip 2023 · Diagnosis |. Treatment |. Key Points. Pseudomonas aeruginosa and other members of this group of gram-negative bacilli are opportunistic pathogens that frequently cause hospital-acquired infections, particularly in patients with burn injuries, ventilator dependence, neutropenia, or chronic debility.
15 gru 2022 · Two antipseudomonal drug combination therapy (eg, a beta-lactam antibiotic with an aminoglycoside) is usually recommended for the initial empiric treatment of a pseudomonal...
